<qa>  What is the name of the drug subject is planning on starting?3. Subject is planning on starting lumacaftor-ivacaftor for clinical reasons, with no contraindication for starting the drug OR subject is taking combination drug and had an OGTT done at a partners facility in the 6 months prior to initiating the drug. 